From professional translators, enterprises, web pages and freely available translation repositories.
palivizumab
palivizumabas
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
palivizumab 100 mg
100 mg palivizumabo
Last Update: 2012-04-11
Usage Frequency: 6
Quality:
liquid formulation of palivizumab
skystos formos palivizumabas
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
studies using liquid palivizumab
tyrimai naudojant skystą palivizumabą
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
the active substance is palivizumab.
veiklioji medžiaga yra palivizumabas.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
· the active substance is palivizumab.
-veiklioji medziaga yra palivizumabas.
Last Update: 2008-03-04
Usage Frequency: 2
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
it contains the active substance palivizumab.
jo sudėtyje yra veikliosios medžiagos palivizumabo.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
each 1 ml vial contains 100 mg of palivizumab.
kiekviename 1 ml flakone yra 100 mg palivizumabo.
Last Update: 2017-04-26
Usage Frequency: 2
Quality:
3 x 15 = 0.45 ml palivizumab dose per month.
3 x 15 = 0, 45 ml palivizumabo per mėnesį.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
3 x 15 = 0.45 ml palivizumab dose per month 100
100
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
synagis 100 mg powder for solution for injection palivizumab
synagis 100 mg milteliai injekciniam tirpalui palivizumabas i.m.
Last Update: 2017-04-26
Usage Frequency: 2
Quality:
no serious adverse events related to palivizumab were reported.
negauta pranesim apie sunkius su palivizumabu susijusius nepalankius vykius.
Last Update: 2008-03-04
Usage Frequency: 2
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
synagis 100 mg powder for solution for injection palivizumab intramuscular
synagis 100 mg milteliai injekciniam tirpalui palivizumabas vartoti raumenis
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
synagis 100 mg powder and solvent for solution for injection palivizumab
synagis 100 mg milteliai ir tirpiklis injekciniam tirpalui palivizumabas
Last Update: 2017-04-26
Usage Frequency: 14
Quality:
one ml of synagis solution for injection contains 100 mg of palivizumab.
viename ml synagis injekcinio tirpalo yra 100 mg palivizumabo
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
the active substance in synagis, palivizumab, is a monoclonal antibody.
synagis veiklioji medžiaga palivizumabas yra monokloninis antikūnas.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
100 mg palivizumab, providing 100 mg/ml of palivizumab when reconstituted as recommended.
istirpinus pagal nurodymus susidaro 100 mg/ml pavilizumabo koncentracija.
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
common adverse reactions occurring with palivizumab are fever, rash and injection site reaction.
dažnos nepageidaujamos reakcijos, pasireiškiančios vartojant palivizumabą, yra karščiavimas, išbėrimas ir reakcijos injekcijos vietoje.
Last Update: 2017-04-26
Usage Frequency: 2
Quality:
- each vial contains 50 mg palivizumab, providing 100 mg/ ml of palivizumab when reconstituted
- viename buteliuke yra 50 mg palivizumabo, ištirpinus pagal rekomendacijas gaunamas
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
each vial contains 100 mg palivizumab, providing 100 mg/ ml of palivizumab when reconstituted as recommended.
kiekviename buteliuke yra 100 mg palivizumabo, kurį ištirpinus pagal nurodymus, palivizumabo koncentracija gautame tirpale yra 100 mg/ ml.
Last Update: 2012-04-11
Usage Frequency: 3
Quality: